By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kamada Ltd. 

Kibbutz Beit Kama M.P.

Negev    85325  Israel
Phone: 07-991-2082 Fax: 07-991-2083




Company News
Kamada Ltd. (KMDA) Announces Appointment Of Biopharmaceutical Industry Veteran, Gwen Melincoff, To Its Board Of Directors 2/8/2017 9:36:46 AM
Kamada Ltd. (KMDA) Reports Financial Results For The Fourth Quarter And Full-Year 2016 2/6/2017 10:46:35 AM
Kamada Ltd. (KMDA) To Host Fiscal Year 2016 Financial Results Conference Call On February 6 2/2/2017 10:51:51 AM
Kamada Ltd. (KMDA) Release: Company Announces Positive Scientific Advice Response From The EMA Focused On Alpha-1 Antitrypsin IV For Treatment Of Acute Graft-Versus-Host Disease 1/23/2017 7:09:35 AM
Kamada Ltd. (KMDA) Announces Collaboration Agreement With Yissum Ltd. For Development Of A Recombinant Human Alpha 1 Antitrypsin 11/15/2016 9:23:48 AM
Kedrion And Kamada Ltd. (KMDA) Announce FDA Acceptance Of BLA Submission For Human Rabies Immunoglobulin As A Post-Exposure Treatment 11/7/2016 9:09:44 AM
Kamada Ltd. (KMDA) To Host Third Quarter Financial Results Conference Call On November 10, 2016 At 8:30 Am Eastern Time 11/3/2016 9:04:41 AM
Kamada Ltd. (KMDA) Announces Plan For Phase II/III Clinical Trial With Alpha-1 Antitrypsin IV For Treatment Of Graft-Versus-Host Disease 11/2/2016 7:27:22 AM
Kamada Ltd. (KMDA) Announces Extension Of GLASSIA┬« Supply And Distribution Agreement With Shire (SHPG) With Minimum $237 Million Of Revenue For The Years 2017 To 2020 10/6/2016 7:12:18 AM
Kamada Ltd. (KMDA) To Present A Corporate Overview At The Rodman & Renshaw 18th Annual Investment Conference 9/9/2016 7:34:27 AM